Option Care Health (OPCH) – Investment Analysts’ Weekly Ratings Updates

Option Care Health (NASDAQ: OPCH) has recently received a number of price target changes and ratings updates:

• 10/7/2026 – Option Care Health was given a new $32.05 price target by Truist Financial Corporation.
• 10/7/2026 – Option Care Health had its “market perform” rating reaffirmed by Citizens Jmp.
• 10/7/2026 – Option Care Health had its “market perform” rating reaffirmed by Barrington Research.
• 10/6/2026 – Option Care Health was downgraded by Jefferies Financial Group Inc. from “buy” to “hold”. They now have a $32.05 price target on the stock, up from $28.00.
• 10/6/2026 – Option Care Health was downgraded by William Blair to “market perform”.
• 9/22/2026 – Option Care Health had its “buy” rating reaffirmed by UBS Group AG.
• 9/11/2026 – Option Care Health was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 8/27/2026 – Option Care Health was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 8/11/2026 – Option Care Health was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.